Currently out of the existing stock ratings of Yun Zhong, 48 are a BUY (82.76%), 10 are a HOLD (17.24%).

Yun Zhong

Work Performance Price Targets & Ratings Chart

Analyst Yun Zhong, currently employed carries an average stock price target met ratio of 18.69% that have a potential upside of 25.7% achieved within 89 days. Previously, Yun Zhong worked at BTIG.

Yun Zhong’s has documented 101 price targets and ratings displayed on 17 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 21-Oct-2024.

Wall Street Analyst Yun Zhong

Analyst best performing recommendations are on GRPH (GRAPHITE BIO).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 11/11/2020. The price target of $140 was fulfilled within 2 days with a profit of $5.27 (3.91%) receiving and performance score of 19.56.

Average potential price target upside

AGTC Applied Genetic AVRO AVROBIO MGTA Magenta Therapeutics QURE Uniqure NV SIOX Sio Gene Therapies SRPT Sarepta Therapeutics TSHA Taysha Gene Therapies  PASG Passage Bio AVXL Anavex Life Sciences Corp FOLD Amicus Therapeutics FRLN Freeline Therapeutics Holdings Plc GRPH Graphite Bio BLUE Bluebird bio FUTU Futu Holdings Ltd INSY INSYS Therapeutics RCOR Renovacor SELB Selecta Biosciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$0.4

$0.01 (2.56%)

2 years 29 days ago
(25-Oct-2022)

1/1 (100%)

$0.01 (2.56%)

2

Buy

2 years 30 days ago
(24-Oct-2022)

1/10 (10%)

$13.99 (348.88%)

848

Hold

$12

2 years 30 days ago
(24-Oct-2022)

0/2 (0%)

$2.73 (29.45%)

Hold

2 years 30 days ago
(24-Oct-2022)

0/1 (0%)

$7.55 (308.16%)

Hold

$11

2 years 1 months 25 days ago
(29-Sep-2022)

0/2 (0%)

$6.72 (157.01%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yun Zhong is most bullish on?

Potential upside of $50.77 has been obtained for SRPT (SAREPTA THERAPEUTICS)

Which stock is Yun Zhong is most reserved on?

Potential downside of $8.34 has been obtained for FOLD (AMICUS THERAPEUTICS)

What Year was the first public recommendation made by Yun Zhong?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?